Semaphorin3a signaling, podocyte shape, and glomerular disease

Area of Science:

• Nephrology
• Molecular Biology
• Cell Biology

Background:

• Semaphorin3a (sema3a) is a guidance protein with diverse biological roles.
• In the kidney, sema3a is crucial for development and secreted by podocytes.
• Podocyte-specific sema3a gain-of-function causes glomerular disease post-development.

Purpose of the Study:

• To investigate the role of semaphorin3a (sema3a) in glomerular filtration barrier function.
• To elucidate the molecular mechanisms by which excess sema3a induces kidney disease.

Main Methods:

• Mouse models with podocyte-specific sema3a gain-of-function.
• In vivo assessment of kidney structure and function.
• Analysis of podocyte morphology, nephrin, and αvβ3 integrin expression.
• Identification of protein interactions using co-immunoprecipitation.

Main Results:

• Excess sema3a in podocytes leads to proteinuric glomerular disease.
• Observed effects include foot process effacement, glomerular basement lamination, and endothelial damage.
• Sema3a down-regulates nephrin and inhibits αvβ3 integrin, disrupting podocyte shape.
• A direct interaction between nephrin and plexinA1 (sema3a receptor) was identified.

Conclusions:

• Semaphorin3a acts as an extracellular negative regulator of the glomerular filtration barrier.
• The nephrin-plexinA1 interaction links slit-diaphragm signaling to sema3a.
• Dysregulation of sema3a signaling contributes to proteinuric kidney disease.